# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-072560
Filing Date
2025-05-15
Accepted
2025-05-15 16:04:22
Documents
67
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | sldb-20250331.htm iXBRL | 10-Q | 2467295
2 | EX-31.1 | sldb-ex31_1.htm | EX-31.1 | 16622
3 | EX-31.2 | sldb-ex31_2.htm | EX-31.2 | 16593
4 | EX-32.1 | sldb-ex32_1.htm | EX-32.1 | 10254
5 | EX-32.2 | sldb-ex32_2.htm | EX-32.2 | 10237
6 | GRAPHIC | img247593112_0.jpg | GRAPHIC | 1163815
| Complete submission text file | 0000950170-25-072560.txt |  | 11935742

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | sldb-20250331.xsd | EX-101.SCH | 1411457
70 | EXTRACTED XBRL INSTANCE DOCUMENT | sldb-20250331_htm.xml | XML | 1458692

Mailing Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129
Business Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129 617-337-4680
Solid Biosciences Inc. (Filer) CIK: 0001707502 (see all company filings)

EIN.: 900943402 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38360 | Film No.: 25952567
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)